Disease

Age-Related Macular Degeneration

A progressive macular disease of older adults with dry and neovascular forms that can impair central vision.

Coverage in progress. AssetMemo has not yet run its full census for Wet Age-Related Macular Degeneration, so the assets listed for it are not complete.

Combined attributable cost

$486.2B+

Drug spend

$9.7B+

How this is calculated ↗

2% of total cost is drugs

Sum of 2 indications below.

All assets in Age-Related Macular Degeneration

← Ophthalmology